Hepatitis B Virus (HBV)

CAS No.	Product Name	Inquiry
3034059-40-7	HBV/HDV-IN-4 hydrochloride
3034161-55-9	HBV/HDV-IN-1
3034161-76-4	HBV/HDV-IN-2
3034992-40-7	HBV-IN-46
330461-34-2	DVR-01
3424-98-4	Telbivudine Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names Sebivo (Europe) and Tyzeka (United States). Clinical trials have shown it to be significantly more effective than lamivudine or adefovir, and less likely to cause resistance.
359689-54-6	Valtorcitabine Dihydrochloride 2'-Deoxy-L-cytidine 3'-O-L-valinyl ester 2HCl is a highly prized compound with applications spaning across a wide range, encompassing the reserch of diverse ailments such as cancer, viral infections, as well as autoimmune disorders.
40093-94-5	2'-Deoxy-L-cytidine Torcitabine (2'-Deoxy-L-cytidine) is an antiviral agent. Torcitabine has the potential for chronic hepatitis B virus infection treatment.
40372-00-7	Viramidine Hydrochloride Taribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor, has activity against a wide range of viruses, especially the hepatitis C virus and influenza virus. Taribavirin hydrochloride is a Ribavirin prodrug, is designed to concentrate within the liver to target HCV-infected hepatocytes while minimizing distribution within red blood cells (RBCs) and the development of hemolytic anemia.
441785-24-6	LB80317 LB80317, an active metabolite of LB80380, inhibits HBV DNA synthesis with an EC50 of 0.5 μM, has antiviral effect and has the potential to treat chronic hepatitis B.
441785-25-7	Besifovir Besifovir is an orally available phosphonate nucleotide for the potential treatment of hepatitis B virus infection was well tolerated and also had a good clinical safety profile.
441785-26-8	Besifovir-Dipivoxil-maleate Besifovir Dipivoxil maleate (LB80380 maleate) is an oral prodrug of LB80317. Besifovir Dipivoxil maleate (LB80380 maleate) is effective in hepatitis B virus (HBV) DNA suppression for both treatment-naive and lamivudine-resistant chronic hepatitis B (CHB) patients in preliminary studies.
443908-19-8	Glycosmisic Acid Glycosmisic Acid is found in Brucea javanica.
452967-14-5	IR415 IR415 is an effective anti-HBV drug that inhibits HBV replication by blocking hepatitis B virus X protein (HBx) activity. IR415 selectively interacts with HBx (Kd = 2 nM), blocks HBV-mediated RNAi inhibition and reverses the inhibitory effect of HBx protein on dicer endoribonuclease activity.
475650-36-3	Inarigivir Inarigivir is a dinucleotide prodrug with antiviral and immunomodulatory activity, which has the potential for the treatment of HBV infections.
476617-51-3	Bay 41-4109 less active enantiomer Bay 41-4109 less active enantiomer exhibits less activity than Bay 41-4109 that is a novel class of drugs and inhibits hepatitis B virus (HBV) capsid formation and replication.
50276-98-7	Erythrocentaurin Erythrocentaurin is a natural coumarin compound found in several plants.
526-18-1	Osalmid Osalmid is a ribonucleotide reductase small subunit M2 (RRM2) targeting compound that suppresses RRM2 activity in a concentration-dependent manner.
548-31-2	Oxynitidine
561022-65-9	Alloc-DOX

※ Please kindly note that our services are for research use only.